SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Tenet Healthcare Corp. – ‘8-K’ for 1/22/21

On:  Monday, 1/25/21, at 4:30pm ET   ·   For:  1/22/21   ·   Accession #:  1193125-21-16277   ·   File #:  1-07293

Previous ‘8-K’:  ‘8-K’ on / for 1/11/21   ·   Next:  ‘8-K’ on / for 2/9/21   ·   Latest:  ‘8-K’ on / for 2/29/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/25/21  Tenet Healthcare Corp.            8-K:5       1/22/21   11:170K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     24K 
 7: R1          Document and Entity Information                     HTML     50K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- d98795d8k_htm                       XML     18K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- thc-20210122_def                 XML     40K 
 4: EX-101.LAB  XBRL Labels -- thc-20210122_lab                      XML     65K 
 5: EX-101.PRE  XBRL Presentations -- thc-20210122_pre               XML     41K 
 2: EX-101.SCH  XBRL Schema -- thc-20210122                          XSD     15K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    21K 
11: ZIP         XBRL Zipped Folder -- 0001193125-21-016277-xbrl      Zip     10K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i TENET HEALTHCARE CORP  i false  i 0000070318 0000070318 2021-01-22 2021-01-22 0000070318 us-gaap:CommonStockMember 2021-01-22 2021-01-22 0000070318 us-gaap:SeniorNotesMember 2021-01-22 2021-01-22

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM  i 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report:  i January 22, 2021

(Date of earliest event reported)

 

 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

 i Nevada    i 1-7293    i 95-2557091

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

 i 14201 Dallas Parkway

 i Dallas,  i Texas  i 75254

(Address of principal executive offices, including zip code)

 i (469)  i 893-2200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

 i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbols

 

Name of each exchange

on which registered

 i Common stock $0.05 par value    i THC    i New York Stock Exchange
 i 6.875% Senior Notes due 2031    i THC31    i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company   i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Following his confirmation by the U.S. Senate as Secretary of the U.S. Department of Defense on January 22, 2021, General Lloyd J. Austin III, a member of the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”), notified the Company of his decision to resign from the Board effective January 22, 2021. The size of the Board decreased to 11 at such time. General Austin’s resignation did not result from any disagreement with the Company or the Board.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TENET HEALTHCARE CORPORATION
Date: January 25, 2021      
    By:  

/s/ Audrey Andrews

    Name:   Audrey Andrews
    Title:   Executive Vice President, General Counsel and Corporate Secretary

Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on:1/25/21None on these Dates
For Period end:1/22/21
 List all Filings 
Top
Filing Submission 0001193125-21-016277   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 10:11:17.2am ET